- Types of Eczema
- Child Eczema
- Causes & Triggers
- Living with Eczema
- Eczema Products
- Get Involved
… I am a woman surviving it. July 19, 2016 — Who calls into work sick because of eczema? That’s what I’m sure people thought when I was consistently missing work due to lack of sleep, broken and bleeding skin, and sometimes just feeling too emotionally unstable to hold it together in the office. I […]
Understanding AD’s impact to improve your quality of life July 19, 2016 — People living with atopic dermatitis (AD), the most common and chronic form of eczema, know first-hand the burden AD has on both individuals and families. The impacts reach far beyond the serious effects of the disease symptoms such as itch, pain, and […]
Eczema affects more than 30 million people in the United States. The most common and chronic form of eczema is known as atopic dermatitis (AD). There is currently no cure for eczema or AD. To help raise awareness about the serious impact AD has on individuals and families, the National Eczema Association (NEA) has joined […]
We asked, you answered. The verdict? People living with eczema want more information and more options. This past January, many of you responded to a 6-question online survey to evaluate patient satisfaction and the role of doctors in the treatment of the most serious form of eczema, atopic dermatitis (AD). We learned that the vast majority of […]
Vice President, Advocacy and Access. Tim will be responsible for development and implementation of key advocacy initiatives that will advance NEA’s mission to improve the quality of life for individuals with eczema through research, support, and education. Tim most recently served as President of Foretop, a consulting firm that provided advocacy and business planning services […]
June 9, 2016 – On Monday, June 6, 2016 the pharmaceutical companies Regeneron and Sanofi, reported positive results for the Phase 3 the clinical trial of the new biologic drug, dupilumab, when used in conjunction with a topical corticosteroid by adults to treat moderate-to-severe atopic dermatitis (AD).
By Fatima Lakhani, BS and Peter A. Lio, MD Adapted, with permission, from original publication in Practical Dermatology. Introduction: Atopic dermatitis (AD) is a chronic itchy inflammatory disease that affects a large number of children and adults.1 The suffering is not limited to the skin; patients have increased rates of ADHD, depression, and anxiety.2 The […]
Excerpted from the blog It’s an Itchy Little World, itchylittleworld.com By Jennifer Moyer Darr, LCSW, National Jewish Health in Denver, Colorado. Confidence comes from within and builds over time as children master new skills and develop a sense of competence. While we can’t give our kids with eczema confidence, there are some things we can […]
May 22, 2016 – Nathan lives in Chicago where he is a medical student. He was diagnosed with eczema at two months old and suffered from severe eczema in grade school and high school. Through treatment, great doctors and avoidance of triggers he has been under control since graduating college.
We all play an important role, especially patients, in bringing new treatments to those that need them. Research is like a relay race that scientists can only take so far, and at some point, they must hand the baton to patients to engage in clinical trials to help bring the treatment to reality. The National […]